MediciNova Announces Positive Results From Secondary Analysis Of Phase 2 Trial Of MN-166 Published In The American Journal Of Drug And Alcohol Abuse
MediciNova Inc 
MNOV:
MEDICINOVA ANNOUNCES POSITIVE RESULTS FROM SECONDARY ANALYSIS OF PHASE 2 TRIAL OF MN-166 (IBUDILAST) PUBLISHED IN THE AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE